Plug Power's Political Tailwind Meets a 15% Growth Pledge That Still Needs Proving
Bayer's Second China Nod Lands as Goldman and UBS Lift Their Targets
Nurix Therapeutics stock tumbles after Sanofi ends SAR448272 program
Micron's Triple Whammy: Election Jitters, CXMT Progress and Kioxia's Cautious Outlook
BYD's Bus Offensive Abroad Meets a Profit Test at Home
Qnity Electronics stock gains after Q3 results, outlook raised
Praxis Precision Medicines stock gets 23,219-share hiring grant
Organon stock: Sun Pharma deal remains a growth driver
PPL Corporation stock trades at EUR 31.84 in late quote
FiscalNote stock faces debt pressure as strategic review continues
Mustang Bio stock gets April 2027 Nasdaq deadline
Butterfield stock: Q3 core earnings reach USD 64.2 million
Aurora Cannabis Takeover: Organigram's C$7.80 Bid Comes With Strings Attached
Maui Land & Pineapple stock faces federal water-billing suit
Commerzbank's Sector-Driven Surge Puts November 5 Results in the Spotlight
Lovesac stock gets Wall Street Zen Buy upgrade after EPS beat
NNN REIT stock trades at EUR 37.45 after third-quarter release
Pan American Silver stock posts Q3 profit as gold guidance falls
Perella Weinberg Partners stock gets boost from Q3 rebound
ON Semiconductor stock: Q3 revenue rises 11% as AI demand accelerates
MasTec stock faces margin pressure after record third-quarter backlog
Pinterest stock posts 12% Q3 revenue growth as Europe stalls
Zinzino's October Slowdown Exposes Regional Cracks Beneath 19% Group Growth
Amazon's Cloud Surge Meets a Political Tailwind — and a $42.4 Billion Cash Drain
Renk's Portfolio Overhaul Comes With a Split Timetable and a Forecast That Has to Hold
Myriad Genetics stock lifts outlook after resilient Q3 performance
Knightscope stock: Signals moves from reveal to live operations
NuCana stock: Edison highlights ProTide oncology focus
PLAYSTUDIOS stock regains Nasdaq compliance after reverse split
Palantir's Blockbuster Quarter Collides With a Stalling Order Book
SpaceX's Cash Clock: Why a $175 Billion Forecast Still Leaves a Six-Year Gap
Neurocrine Biosciences stock: Q3 revenue jumps 41%, outlook raised
MaxLinear stock trades at 51.14 euros late Wednesday